Recent Developments in Enhanced External Counterpulsation Therapy for Atherosclerotic Cardiovascular Disease
Department of Cardiovascular,Shaoxing People's Hospital,Shaoxing 312000,China
*Corresponding author:PENG Fang,Chief physician;E-mail:sxrmyypf@126.com
CAI Xiaona and HE Yiping are co-first authors
[1]胡盛寿,高润霖,刘力生,等.《中国心血管病报告2018》概要[J].中国循环杂志,2019,34(3):209-220.DOI:10.3969/j.issn.1000-3614.2019.03.001.
HU S S,GAO R L,LIU L S,et al. Summary of the 2018 report on cardiovascular diseases in China[J]. Chin Circ J,2019,34(3):209-220. DOI:10.3969/j.issn.1000-3614.2019.03.001.
[2]中国心血管健康与疾病报告编写组. 中国心血管健康与疾病报告2019概要[J]. 中国循环杂志,2020,35(9):833-854. DOI:10.3969/j.issn.1000-3614.2020.09.001.
The Writing Committee of the Report on Cardiovascular Health Diseases in China. Report on cardiovascular health and diseases in China 2019:an updated summary[J]. Chin Circ J,2020,35(9):833-854. DOI:10.3969/j.issn.1000-3614.2020.09.001.
[3]BENJAMIN E J,VIRANI S S,CALLAWAY C W,et al. Heart disease and stroke statistics-2018 update:a report from the American heart association[J]. Circulation,2018,137(12):e67-492. DOI:10.1161/CIR.0000000000000558.
[4]国际体外反搏学会,中国康复医学会心血管病专业委员会,中国老年学学会心脑血管病专业委员会. 心血管疾病康复处方——增强型体外反搏应用国际专家共识[J]. 中华内科学杂志,2014,53(7):587-590. DOI:10.3760/cma.j.issn.0578-1426.2014.07.024.
[5]GUROVICH A N,BRAITH R W. Enhanced external counterpulsation creates acute blood flow patterns responsible for improved flow-mediated dilation in humans[J]. Hypertens Res,2013,36(4):297-305. DOI:10.1038/hr.2012.169.
[6]LEONG D P,JOSEPH P G,MCKEE M,et al. Reducing the global burden of cardiovascular disease,part 2:prevention and treatment of cardiovascular disease[J]. Circ Res,2017,121(6):695-710. DOI:10.1161/CIRCRESAHA.117.311849.
[7]RAY K K,SESHASAI S R,WIJESURIYA S,et al. Effect of intensive control of glucose on cardiovascular outcomes and death in patients with diabetes mellitus:a meta-analysis of randomised controlled trials[J]. Lancet,2009,373(9677):1765-1772. DOI:10.1016/s0140-6736(09)60697-8.
[8]CONTROL GROUP,TURNBULL F M,ABRAIRA C,et al. Intensive glucose control and macrovascular outcomes in type 2 diabetes[J]. Diabetologia,2009,52(11):2288-2298. DOI:10.1007/s00125-009-1470-0.
[9]ROSS S,GERSTEIN H C,EIKELBOOM J,et al. Mendelian randomization analysis supports the causal role of dysglycaemia and diabetes in the risk of coronary artery disease[J]. Eur Heart J,2015,36(23):1454-1462. DOI:10.1093/eurheartj/ehv083.
[10]HOLMAN R R,PAUL S K,BETHEL M A,et al. 10-year follow-up of intensive glucose control in type 2 diabetes[J]. N Engl J Med,2008,359(15):1577-1589. DOI:10.1056/nejmoa0806470.
[11]GERSTEIN H C,MILLER M E,ISMAIL-BEIGI F,et al. Effects of intensive glycaemic control on ischaemic heart disease:analysis of data from the randomised,controlled ACCORD trial[J]. Lancet,2014,384(9958):1936-1941. DOI:10.1016/s0140-6736(14)60611-5.
[12]KESKIN K,KILCI H,AKSAN G,et al. Serum oxidized low-density lipoprotein level as a marker of oxidative stress in patients undergoing hyperbaric oxygen therapy[J]. Turk Kardiyol Dern Ars,2017,45(6):533-537. DOI:10.5543/tkda.2017.28302.
[13]AL-WAILI N S,BUTLER G J,BEALE J,et al. Influences of hyperbaric oxygen on blood pressure,heart rate and blood glucose levels in patients with diabetes mellitus and hypertension[J]. Arch Med Res,2006,37(8):991-997. DOI:10.1016/j.arcmed.2006.05.009.
[14]BURESH R. Exercise and glucose control[J]. J Sports Med Phys Fit,2014,54(4):373-382.
[15]LEY S H,HAMDY O,MOHAN V,et al. Prevention and management of type 2 diabetes:dietary components and nutritional strategies[J]. Lancet,2014,383(9933):1999-2007. DOI:10.1016/s0140-6736(14)60613-9.
[16]SARDINA P D,MARTIN J S,DZIEZA W K,et al. Enhanced external counterpulsation(EECP)decreases advanced glycation end products and proinflammatory cytokines in patients with non-insulin-dependent type II diabetes mellitus for up to 6 months following treatment[J]. Acta Diabetol,2016,53(5):753-760. DOI:10.1007/s00592-016-0869-6.
[17]SARDINA P D,MARTIN J S,AVERY J C,et al. Enhanced external counterpulsation(EECP)improves biomarkers of glycemic control in patients with non-insulin-dependent typeⅡ diabetes mellitus for up to 3 months following treatment[J]. Acta Diabetol,2016,53(5):745-752. DOI:10.1007/s00592-016-0866-9.
[18]SAHEBJAMI F,MADANI F R,KOMASI S,et al. Refractory angina frequencies during 7 weeks treatment by enhanced external counterpulsation in coronary artery disease patients with and without diabetes[J]. Ann Card Anaesth,2019,22(3):278-282. DOI:10.4103/aca.aca_86_18.
[19]LEON M B,SMITH C R,MACK M J,et al. Transcatheter or surgical aortic-valve replacement in intermediate-risk patients[J]. N Engl J Med,2016,374(17):1609-1620. DOI:10.1056/nejmoa1514616.
[20]ETTEHAD D,EMDIN C A,KIRAN A,et al. Blood pressure lowering for prevention of cardiovascular disease and death:a systematic review and meta-analysis[J]. Lancet,2016,387(10022):957-967. DOI:10.1016/S0140-6736(15)01225-8.
[21]LEONG D P,JOSEPH P G,MCKEE M,et al. Reducing the global burden of cardiovascular disease,part 2:prevention and treatment of cardiovascular disease[J]. Circ Res,2017,121(6):695-710. DOI:10.1161/CIRCRESAHA.117.311849.
[22]CAMPBELL A R,SATRAN D,ZENOVICH A G,et al. Enhanced external counterpulsation improves systolic blood pressure in patients with refractory angina[J]. Am Heart J,2008,156(6):1217-1222. DOI:10.1016/j.ahj.2008.07.024.
[23]BONDESSON S,PETTERSSON T,OHLSSON O,et al. Effects on blood pressure in patients with refractory angina pectoris after enhanced external counterpulsation[J]. Blood Press,2010,19(5):287-294. DOI:10.3109/08037051003794375.
[24]MAY O,KHAIR W A. Enhanced external counterpulsation has no lasting effect on ambulatory blood pressure[J]. Clin Cardiol,2013,36(1):21-24. DOI:10.1002/clc.22045.
[25]BECK D T,CASEY D P,MARTIN J S,et al. Enhanced external counterpulsation reduces indices of central blood pressure and myocardial oxygen demand in patients with left ventricular dysfunction[J]. Clin Exp Pharmacol Physiol,2015,42(4):315-320. DOI:10.1111/1440-1681.12367.
[26]SARDINA P D,MARTIN J S,DZIEZA W K,et al. Enhanced external counterpulsation(EECP)decreases advanced glycation end products and proinflammatory cytokines in patients with non-insulin-dependent type II diabetes mellitus for up to 6 months following treatment[J]. Acta Diabetol,2016,53(5):753-760. DOI:10.1007/s00592-016-0869-6.
[27]CASEY D P,BECK D T,NICHOLS W W,et al. Effects of enhanced external counterpulsation on arterial stiffness and myocardial oxygen demand in patients with chronic angina pectoris[J]. Am J Cardiol,2011,107(10):1466-1472. DOI:10.1016/j.amjcard.2011.01.021.
[28]ZHANG C M,LIU X J,WANG X M,et al. Efficacy of enhanced external counterpulsation in patients with chronic refractory angina on Canadian cardiovascular society(CCS)angina class:an updated meta-analysis[J]. Medicine,2015,94(47):e2002. DOI:10.1097/MD.0000000000002002.
[29]ABDELWAHAB A A,ELSAIED A M. Can enhanced external counter pulsation as a non-invasive modality be useful in patients with ischemic cardiomyopathy after coronary artery bypass grafting?[J]. Egypt Heart J,2018,70(2):119-123. DOI:10.1016/j.ehj.2018.01.002.
[30]MARTIN J S,BECK D T,ARANDA J M,et al. Enhanced external counterpulsation improves peripheral artery function and glucose tolerance in subjects with abnormal glucose tolerance[J]. J Appl Physiol(1985),2012,112(5):868-876. DOI:10.1152/japplphysiol.01336.2011.
[31]XU L,CHEN X,CUI M,et al. The improvement of the shear stress and oscillatory shear index of coronary arteries during Enhanced External Counterpulsation in patients with coronary heart disease[J]. PLoS One,2020,15(3):e0230144. DOI:10.1371/journal.pone.0230144.
[32]LAWSON W E,HUI J C,KENNARD E D,et al. Enhanced external counterpulsation is cost-effective in reducing hospital costs in refractory angina patients[J]. Clin Cardiol,2015,38(6):344-349. DOI:10.1002/clc.22395.
[33]MAY O,S?GAARD H J. Enhanced external counterpulsation is an effective treatment for depression in patients with refractory angina pectoris[J]. Prim Care Companion CNS Disord,2015,17(4):10.4088/PCC.14m01748. DOI:10.4088/pcc.14m01748.
[34]QIN X X,DENG Y Y,WU D D,et al. Does enhanced external counterpulsation(EECP)significantly affect myocardial perfusion?:A systematic review & meta-analysis[J]. PLoS One,2016,11(4):e0151822. DOI:10.1371/journal.pone.0151822.
[35]LIN S,XIAO-MING W,GUI-FU W. Expert consensus on the clinical application of enhanced external counterpulsation in elderly people(2019)[J]. Aging Med(Milton),2020,3(1):16-24. DOI:10.1002/agm2.12097.
[36]XIONG L,LIN W H,HAN J H,et al. Enhancing cerebral perfusion with external counterpulsation after ischaemic stroke:how long does it last?[J]. J Neurol Neurosurg Psychiatry,2016,87(5):531-536. DOI:10.1136/jnnp-2014-309842.
[37]LIN W,XIONG L,HAN J,et al. Increasing pressure of external counterpulsation augments blood pressure but not cerebral blood flow velocity in ischemic stroke[J]. J Clin Neurosci,2014,21(7):1148-1152. DOI:10.1016/j.jocn.2013.09.023.
[38]LIN W,XIONG L,HAN J,et al. External counterpulsation augments blood pressure and cerebral flow velocities in ischemic stroke patients with cerebral intracranial large artery occlusive disease[J]. Stroke,2012,43(11):3007-3011. DOI:10.1161/strokeaha.112.659144.
[39]XIONG L,TIAN G,WANG L,et al. External counterpulsation increases beat-to-beat heart rate variability in patients with ischemic stroke[J]. J Stroke Cerebrovasc Dis,2017,26(7):1487-1492. DOI:10.1016/j.jstrokecerebrovasdis.2017.03.007.
[40]TIAN G,XIONG L,LIN W,et al. External counterpulsation reduces beat-to-beat blood pressure variability when augmenting blood pressure and cerebral blood flow in ischemic stroke[J]. J Clin Neurol,2016,12(3):308-315. DOI:10.3988/jcn.2016.12.3.308.
[41]RAZUMOV A N,éNEEVA M A,KOSTENKO E V,et al. The depressive disorders during the early rehabilitation period following preceding ischemic stroke:the possibilities for the application of the enhanced external counterpulsation method[J]. Vopr Kurortol Fizioter Lech Fiz Kult,2016,93(1):4-10. DOI:10.17116/kurort201614-10.
[42]ABOYANS V,SEVESTRE M A,DéSORMAIS I,et al. Epidemiology of lower extremity artery disease[J]. Presse Med,2018,47(1):38-46. DOI:10.1016/j.lpm.2018.01.012.
[43]苏苗苗,陈忠. 股腘动脉粥样硬化性闭塞症的腔内治疗进展[J]. 心肺血管病杂志,2015,34(2):150-153. DOI:10.3969/j.issn.1007-5062.2015.02.020.
[44]BADTIEVA V A,VOROSHILOVA D N,SICHINAVA N V. Use of enhanced external counterpulsation in the treatment and rehabilitation of patients with atherosclerosis obliterans of the lower extremity[J]. Vopr Kurortol Fizioter Lech Fiz Kult,2019,96(4):5-11. DOI:10.17116/kurort2019960415.
[45]BUSCHMANN E E,BRIX M,LI L,et al. Adaptation of external counterpulsation based on individual shear rate therapy improves endothelial function and claudication distance in peripheral artery disease[J]. Vasa,2016,45(4):317-324. DOI:10.1024/0301-1526/a000544.
[46]ZHU W,LIAO R,CHEN Y,et al. Effect of enhanced extracorporeal counterpulsation in patients with non-arteritic anterior ischaemic optic neuropathy[J]. Graefes Arch Clin Exp Ophthalmol,2015,253(1):127-133. DOI:10.1007/s00417-014-2823-z.